Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions.

Journal

Retrovirology
ISSN: 1742-4690
Titre abrégé: Retrovirology
Pays: England
ID NLM: 101216893

Informations de publication

Date de publication:
29 07 2020
Historique:
entrez: 31 7 2020
pubmed: 31 7 2020
medline: 31 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s12977-020-00530-4 PMID: 32727499 PMC: PMC7389342
pubmed: 32727499
doi: 10.1186/s12977-020-00530-4
pii: 10.1186/s12977-020-00530-4
pmc: PMC7389342
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Commentaires et corrections

Type : ErratumFor

Références

Retrovirology. 2013 May 30;10:57
pubmed: 23721378

Auteurs

Belete Ayele Desimmie (BA)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Rik Schrijvers (R)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Jonas Demeulemeester (J)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Doortje Borrenberghs (D)

Laboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.

Caroline Weydert (C)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Wannes Thys (W)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Sofie Vets (S)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Barbara Van Remoortel (B)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Johan Hofkens (J)

Laboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.

Jan De Rijck (J)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Jelle Hendrix (J)

Laboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.

Norbert Bannert (N)

Centre for HIV and Retrovirology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.

Rik Gijsbers (R)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Frauke Christ (F)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.

Zeger Debyser (Z)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium. Zeger.debyser@med.kuleuven.be.

Classifications MeSH